KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Total Non-Current Liabilities (2016 - 2025)

Astrazeneca has reported Total Non-Current Liabilities over the past 11 years, most recently at $34.7 billion for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $34.7 billion for Q4 2025, down 1.59% from a year ago — trailing twelve months through Dec 2025 was $34.7 billion (down 1.59% YoY), and the annual figure for FY2025 was $34.7 billion, down 1.59%.
  • Total Non-Current Liabilities for Q4 2025 was $34.7 billion at Astrazeneca, down from $35.3 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for AZN hit a ceiling of $43.5 billion in Q4 2021 and a floor of $31.4 billion in Q4 2023.
  • Median Total Non-Current Liabilities over the past 5 years was $34.7 billion (2025), compared with a mean of $35.6 billion.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 41.25% in 2021 and later decreased 23.8% in 2022.
  • Astrazeneca's Total Non-Current Liabilities stood at $43.5 billion in 2021, then decreased by 23.8% to $33.1 billion in 2022, then decreased by 5.19% to $31.4 billion in 2023, then grew by 12.37% to $35.3 billion in 2024, then fell by 1.59% to $34.7 billion in 2025.
  • The last three reported values for Total Non-Current Liabilities were $34.7 billion (Q4 2025), $35.3 billion (Q4 2024), and $31.4 billion (Q4 2023) per Business Quant data.